Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Intensive Care Med ; 30(1): 68-74, 2004 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-14634726

RESUMO

OBJECTIVE: To examine whether cytokine concentrations change in the pulmonary compartment during the development of ventilator-associated pneumonia (VAP). DESIGN: Non-directed bronchial lavage (NBL) was performed every 48 h in critically ill mechanically ventilated patients. Serial measurements of the cytokines tumor necrosis factor (TNF) alpha, interleukin (IL)-1alpha, IL-1beta, IL-6, and IL-10 and the cytokine inhibitors soluble TNFalpha receptor type I (sTNFalphaRI), IL-1 receptor antagonist (IL-1Ra) and soluble IL-1 receptor II (sIL-1RII) were performed on the NBL fluid and matching plasma samples by ELISA. SETTING: An adult medical and surgical university hospital intensive care unit. PATIENTS: Nine patients who developed VAP and nineteen patients who did not develop VAP served as controls. INTERVENTIONS: None. RESULTS: Plasma concentrations of the measured cytokines and cytokine inhibitors did not change significantly in any patients. In control patients, NBL fluid concentrations of sIL-1RII decreased significantly over time (P=0.01). In patients who developed VAP, NBL fluid concentrations of TNFalpha, sTNFalphaRI, IL-1alpha, and IL-1beta increased significantly (P=0.002, P=0.03, P=0.04 and P=0.02, respectively). Furthermore, NBL fluid/plasma concentration ratios for TNFalpha, sTNFalphaRI, IL-1alpha, IL-1Ra and IL-6 increased significantly as VAP developed (P=0.001, P=0.001, P=0.04, P=0.03, and P=0.04, respectively). CONCLUSION: Our results suggest that the production of important cytokines and cytokine inhibitors is compartmentalised within the lung in critically ill mechanically ventilated patients who develop VAP.


Assuntos
Líquido da Lavagem Broncoalveolar/citologia , Citocinas/análise , Citocinas/sangue , Pneumonia Bacteriana/sangue , Pneumonia Bacteriana/etiologia , Respiração Artificial/efeitos adversos , Adulto , Idoso , Antígenos CD/análise , Antígenos CD/sangue , Compartimentos de Líquidos Corporais , Estudos de Casos e Controles , Citocinas/antagonistas & inibidores , Citocinas/imunologia , Inglaterra , Ensaio de Imunoadsorção Enzimática , Feminino , Hospitais Universitários , Humanos , Proteína Antagonista do Receptor de Interleucina 1 , Interleucina-1/análise , Interleucina-1/sangue , Interleucina-10/análise , Interleucina-10/sangue , Interleucina-6/análise , Interleucina-6/sangue , Modelos Lineares , Masculino , Pessoa de Meia-Idade , Pneumonia Bacteriana/imunologia , Receptores de Interleucina-1/análise , Receptores de Interleucina-1/sangue , Receptores Tipo I de Interleucina-1 , Receptores do Fator de Necrose Tumoral/análise , Receptores do Fator de Necrose Tumoral/sangue , Receptores Tipo I de Fatores de Necrose Tumoral , Sialoglicoproteínas/análise , Sialoglicoproteínas/sangue , Fatores de Tempo , Fator de Necrose Tumoral alfa/análise , Fator de Necrose Tumoral alfa/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...